Castle Creek Biosciences, Inc.
6 private offerings reported to the SEC on Form D since 2016, $839.8M sold in all. Biotech, PA.
- Form D offerings: 6
- Reported sold: $839.8M
- Newest: Feb 25, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Feb 25, 2025 | $75.0M | $75.0M | Castle Creek Biosciences, Inc.Biotech · PA | Not amended | 0001756702-25-000001 |
| May 2, 2022 | $112.8M | $112.8M | Castle Creek Biosciences, Inc.Biotech · PA | Not amended | 0001756702-22-000002 |
| Feb 3, 2022 | $11.8M | $11.8M | Castle Creek Biosciences, Inc.Biotech · PA | Not amended | 0001756702-22-000001 |
| Jul 9, 2021 | $25.0M | $25.0M | Castle Creek Biosciences, Inc.Biotech · PA | Not amended | 0001756702-21-000002 |
| Jan 21, 2020 | $54.6M | $54.6M | Castle Creek Pharmaceutical Holdings, Inc.Pharma · NJ | Not amended | 0001756702-20-000001 |
| Oct 24, 2018 | $560.5M | $560.5M | Castle Creek Pharmaceutical Holdings, Inc.Pharma · NJ | Not amended | 0001756702-18-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Parsippany, Nj
- Incorporated in
- DE
- SEC industry
- Pharmaceutical Preparations
- Former names
- Castle Creek Pharmaceutical Holdings, Inc.
- All SEC filings
- CIK 1756702 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR